Systemic and splanchnic metabolic response to exogenous human growth hormone

Surgery

Volumn 123, Issue 5, 1998, Pages 528-538

  Dahn, Michael S ^a,b   Lange, M Patricia ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

AMINO ACID URINE LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG RESISTANCE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE RESISTANCE; HUMAN; INFLAMMATION; LIVER BLOOD FLOW; LIVER INJURY; METABOLISM; NUTRITIONAL STATUS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SEPSIS; SPLANCHNIC BLOOD FLOW; SUBCUTANEOUS DRUG ADMINISTRATION; SURGICAL PATIENT; TREATMENT OUTCOME; UREA BLOOD LEVEL; VENOUS OXYGEN TENSION;

EID: 0031946053     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.1998.86924     Document Type: Article

References (52)

1. Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 1987;27:262.
2. Chwals WJ, Bistrian BR. Role of exogenous growth hormone and insulin-like growth factor I in malnutrition and acute metabolic stress: a hypothesis. Crit Care Med 1991;19:1317-22.
3. Manson JM, Wilmore DW. Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding. Surgery 1986;100:188-97.
4. Ward, HC, Halliday D, Sim AJW. Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 1987;206:56-61.
5. Byrne TA, Morrissey TB, Gatzen C, et al. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring rehabilitation. Ann Surg 1993;218:400-18.
6. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch Surg 1991;126:38-43.
7. Declan Fleming RY, Rutan RL, Jahoor F, Barrow RE, Wolfe RR, Herndon DN. Effect of recombinant human growth hormones on catabolic hormone and free fatty acids following thermal injury. J Trauma 1992;32:698-702.
8. Peterson SR, Holaday NJ, Jeevanandam M. Enhancement of protein synthesis efficiency in parenterally fed trauma victims by adjuvant recombinant human growth hormone. J Trauma 1994;36:726-33.
9. Voerman BJ, Strack van Schijndel JM, Groeneveld ABJ, de Boer H, Nauta JP, Thijs LG. Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial. Crit Care Med 1995;23:665-73.
10. Ziegler TR, Young LS, Ferrari-Balivierc E, Demling RH, Wilmore DW. Use of human growth hormone combined with nutritional support in a critical care unit. JPEN 1990;14:574-81.
11. Roth E, Valentini L, Semsroth M, Holzenbein T, Winkler S, Blum WF, et al. Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries. J Trauma 1995;38:136-41.
12. Gottardis M, Benzer A, Holler W, Luger TJ, Puhringer F, Hackl J. Improvement of septic syndrome after administration of recombinant human growth hormone (rhGH)? J Trauma 1991;31:81-6.
13. Dahn MS, Lange MP, Jacobs LA. Insulin-like growth factor I production is inhibited in human sepsis. Arch Surg 1988;123:1409-14.
14. Schwander JC, Hauri C, Zapf J, et al. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 1983;113:297.
15. Underwood LE, Clemmons DR, D'Ercole AJ, VanWyk JJ. Paracrine functions of somatomedins. Clin Endocrinol Metab 1986;15:59-77.
16. Bone RC, Fein AM, Balk RA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
17. Noma A, Okabe H, Kita M. A new colorimetric micro-determination of free fatty acids in serum. Clin Chim Acta 1973;43:317-20.
18. Rowell LB. Measurement of hepatic splanchnic blood flow in man by dye techniques. In: Bloomfield DA, editor. Dye curres: the theory and practice of indicator dilution. Baltimore: University Park Press; 1974. p 209-29.
19. Rodgers BD. Catabolic hormones and growth hormone resistance in acquired immunodeficiency syndrome and other catabolic states. Proc Soc Exp Biol Med 1996;212:324-31.
20. Harrison LE, Blumberg D, Port JL, Burt M, Hochwald S. Perioperative growth hormone improves wound healing and immunologic function in rats receiving adriamycin. J Surg Res 1995;58:646-50.
21. Dahn MS, Mitchell RA, Smith S, et al. Altered immunologic function and nitrogen metabolism associated with depression of plasma growth hormone. JPEN 1984;8:690-4.
22. Auernbammer CJ, Strasburger CJ. Effects of growth hormone and insulin like growth factor I on the immune system. Eur J Endocrinol 1995;133:635-45.
23. Warburton C, Powell-Braxton L. Mouse models of IGF-I deficiency generated by gene targeting. Receptor 1995;5:35-41.
24. Turner JD, Rotwein P, Novakofshki J, Bechtel PJ. Induction of mRNA for IGF-I and II during growth hormone stimulated muscle hypertrophy. Am J Physiol 1989;255:E513-7.
25. Guler HP, Zapf J, Scheiwiller E, Froesch ER. Recombinant insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci 1988;85:4889-93.
26. Wojnar MM, Fan J, Frost RA, Gelato MC, Lang CH. Alterations in the insulin-like growth factor system in trauma patients. Am J Physiol 1995;268:R970-7.
27. Ross R, Miell J, Freeman E, Jones J, Matthews D, Preece M, et al. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clin Endocrinol 1991;35:47-54.
28. Dahn M, Kirkpatrick JR, Bowman D. Sepsis, glucose intolerance, and protein malnutrition: a metabolic paradox. Arch Surg 1980;115:1415-8.
29. Dahn MS, Jacobs LA, Lange MP, Smith S, Mitchell RA. Endocrine mediators of metabolism associated with injury and sepsis. JPEN 1980;10:253-7.
30. Voerman HJ, Strack van Schijndel RJM, Groeneveld ABJ, de Boer H, Nanta JP, van der Veen EA, et al. Effect of recombinant human growth hormone in patients with severe sepsis. Ann Surg 1992;216:648-55.
31. Peterson SK, Jeevanandan M, Holaday NJ. Adjuvant recombinant human growth hormone stimulates insulin-like growth factor binding protein-3 secretion in critically ill trauma patients. J Trauma 1995;39:295-300.
32. Koea JB, Douglas RG, Shaw JHF, Gluckman PD. Growth hormone therapy initiated before starvation ameliorates the catabolic state and enhances the protein-sparing effect of total parenteral nutrition. Br J Surg 1993;80:740-4.
33. Ketelslegers JM, Maiter D, Maes M, Underwood LE, Thissen JP. Nutritional regulation of insulin-like growth factor-I. Metabolism 1995;44:50-7.
34. Straus DS, Takemoto CD. Effect of fasting on insulin-like growth factor-I (IGF-I) and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver. Mol Endocrinol 1990;4:91-100.
35. Jeevanandam M, Ramios L, Shamos RF, Schiller WR. Decreased growth hormone levels in the catabolic phase of severe injury. Surgery 1992;111:495-502.
36. Erickson S. Insulin-like growth factor in chronic liver disease. J Intern Med 1994;235:93-4.
37. Hanaire-Broutin H, et al. Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycemic control and hepatic insulinization. Diabetes Metabolism 1996;22:245-50.
38. Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. Growth hormone, insulin like growth factor-I and insulin like growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology 1995;21:680-8.
39. Nilsson A, Isgaard J, Lindahl A, Dahlstrom A, Skottner A, Isaksson OGP. Regulation by growth hormone of numbers of chondrocytes containing IGF-I in rat growth plate. Science 1986; 233:571-4.
40. Frybury DA, Gelfand RA, Barrett EJ. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol 1991;260:E499-504.
41. Manson JM, Wilmore DW. Positive nitrogen balance with human growth hormone and hypocalorie intravenous feeding. Surgery 1986;100:188-97.
42. Miaaland M, Unneberg K, Bioro T, Revhauo A. Growth hormone treatment after abdominal surgery decreased carbohydrate oxidation and increased fat oxidation in patients with total parenteral nutrition. Metabolism 1993;42:185-90.
43. Sirck A, Vranic M, Sirek OV, Vigas M, Policona Z. Effect of growth hormone on acute glucagon and insulin release. Am J Physiol 1979;237:E107-12.
44. O'Neal DN, Kalfas A, Dunning PL, Christopher MJ, Sawyer SD, Ward GM, et al. The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis. J Clin Endocrinol Metab 1994;79:975-83.
45. Dahn MS, Mitchell RA, Lange MP, Smith S, Jacobs LA. Hepatic metabolic response to injury and sepsis. Surgery 1995;117:520-30.
46. Snel YE, Doeroa ME, Brummer RJ, Zelissen PM, Zonderland ML, Koppeschaar HP. Resting metabolic rate, body composition and related hormonal parameters in growth hormone-deficient adults before and after growth hormone replacement therapy. Eur J Endocrinol 1995;133:445-50.
47. Fanelli C, Calderone S, Eoifano L, et al. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest 1993;92:1617-22.
48. Nagano K, Gelman S, Parks DA, Bradley EL. Hepatic oxygen supply-uptake relationship and metabolism during anesthesia in miniature pigs. Anesthesiology 1990;72:902-10.
49. Kainuma M, Nakashima K, Sakuma I, et al. Hepatic venous hemoglobin oxygen saturation predicts liver dysfunction after hepatectomy. Anesthesiology 1992;76:379-86.
50. Nishizawa F, Takada Y, Yamaguchi T, et al. Effect of growth hormone on hepatic energy metabolism in normal rabbit liver. Eur Surg Res 1995;27:93-9.
51. Dahn MS, Lange MP, Jacobs LA. Central mixed and splanchnic venous saturation monitoring. Intensive Care Med 1988;14:373-8.
52. Schmidt W, Dore S, Hiloendorf A, Stranch S, Gareau R, Brisson GR. Effects of exercise during normoxia and hypoxia on growth hormone-insulin-like growth factor I axis. Eur J Appl Physio Occ Physiol 1995;71:424-30.